CIK 0001401040
- Non-accelerated filer
- Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- Operating
- Phone
- +1 763-496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-01-02 | Semba Charles Pauling Director | Grant or award | +3,355 | $8.42 | $28K | 47,963 |
| 2025-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +32,162 | 32,162 | ||
| 2025-01-02 | Semba Charles Pauling Director | Grant or award | +5,290 | $5.34 | $28K | 44,608 |
| 2024-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-01-02 | Semba Charles Pauling Director | Grant or award | +9,375 | $2.80 | $26K | 39,318 |
| 2023-06-23 | Semba Charles Pauling Director | Purchase | +12,787 | $3.91 | $50K | 29,943 |
| 2023-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +16,968 | 16,968 | ||
| 2023-01-03 | Semba Charles Pauling Director | Grant or award | +17,156 | $1.53 | $26K | 17,156 |
| 2022-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +13,222 | 13,222 | ||
| 2021-07-15 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +18,786 | 18,786 |
Page 1 of 1 · 11 trades